cancer news

A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with more than a two-fold increased risk of prostate cancer, earlier disease onset, and prostate cancer with more aggressive features.

An Indiana University study found that young, female breast cancer survivors often suffer from sexual and intimate relationship issues and are interested in using sexual enhancement products to treat these problems.The study, 'Young Female Breast Cancer Survivors: Their sexual function and interest in sexual enhancement products and services,' was published Nov. 4 in the journal Cancer Nursing.The study was funded by The Patty Brisben Foundation, a non-profit organization dedicated to furthering research related to women's sexual health.read more

Dense networks of blood vessels thought to spur cancer's growth could actually hinder rather than promote tumor progression, according to a new study at the University of California, San Diego.The findings partly explain why drugs designed to treat cancer by strangling its blood supply have been disappointing when used alone and why those treatments are more effective when combined with traditional chemotherapy.read more

A research study to recruit foreign language speaking cancer patients through Australian Cancer Registries will begin in New South Wales this month.

Reports from Taiwan say the sperm taken from a man with testicular cancer 13 years ago has been successfully used to impregnate his wife.

UroToday.com - In the October 1, 2008 issue of Clinical Cancer Research, Dr. Johann de Bono and colleagues presented exciting data indicating that circulating tumor cells (CTC) predict overall survival (OS) in patients with castration-resistant prostate cancer (CRPC).

An Indiana University study found that young, female breast cancer survivors often suffer from sexual and intimate relationship issues and are interested in using sexual enhancement products to treat these problems. The study, 'Young Female Breast Cancer Survivors: Their sexual function and interest in sexual enhancement products and services,' was published Nov. 4 in the journal Cancer Nursing.

BERKELEY, CA (UroToday.com) - High-intensity focused ultrasonography (HIFU) is an approach to the treatment of prostate cancer (CaP). While not FDA approved in the US, it is approved and gaining popularity in many countries. HIFU utilizes acoustic energy delivered from a transducer, resulting in tissue destruction in the path of the ultrasound beam. In the online edition of Urology, a team of German physicians headed by Dr. Andreas Blana reported 8-year outcomes using HIFU.

DxS, a personalised medicine company and market leaders in the provision of companion diagnostics are pleased to announce the addition of a PI3K Mutation Detection Kit to their portfolio of oncogene mutation products. PI3K is a biomarker assessed during the evaluation of the tyrosine kinase inhibitors targeting the EGFR pathway. The PI3K-AKT pathway is activated in a variety of tumour types resulting in cell growth and proliferation.

UroToday.com - Our single center study on robotic partial nephrectomy represents one of the largest series in the world. The study, which shows results comparable, if not better, than most laparoscopic series, is significant for the relatively short ischemic times and excellent pathological outcomes. Ultimately, the goal of robotic partial nephrectomy is similar to the open counterpart: to provide excellent cancer control with preservation of long term renal functional outcomes.